Molecular studies revealed that Mcl-1 plays an even more important role than Bcl-2/Bcl-xL in protecting AML cells from apoptosis [11] and, therefore, agents inhibiting Mcl-1 need to be developed. This evidence concerns the gene MCL1 and acute myeloid leukemia.